A scoping review of grey zone use for transfusion‐transmitted infection screening among blood donors

GZ evaluation showed a small yet significant risk of TTI from samples identified within the GZ range. There is further need for follow-up studies to establish TTI risk from repeat reactive or indeterminate samples, which will help in establishing uniform protocols for GZ samples.